# Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia

> **NCT00110058** · PHASE2 · COMPLETED · sponsor: **Fred Hutchinson Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** recombinant interferon alfa
- **BIOLOGICAL:** therapeutic allogeneic lymphocytes
- **DRUG:** cyclosporine
- **DRUG:** fludarabine phosphate
- **DRUG:** imatinib mesylate
- **DRUG:** mycophenolate mofetil
- **PROCEDURE:** peripheral blood stem cell transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00110058
- **Lead sponsor:** Fred Hutchinson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110058, "Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00110058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*